Creative Biolabs-Immuno-oncology

Anti-DLL3 (clone DL30Z1G) SynExpress T7-mCh-TF-E Modified CD8+ T cells (CAT#: ITS-1224-CR2125)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLL3 (clone DL30Z1G). We employs the pUC (T7-mCherry-TFIIA-EcoRI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Adaptive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
DLL3
Clone
DL30Z1G
Species Reactivity
Mouse
Cell Source
Modified CD8+ T cells
Sensor Gene
mCherry
Promoter
T7
Effector Gene
TFIIA
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
pUC
Transformation Accuracy
0.95
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving